Other Clinical Trial - Effects of Exercise on VLDL-TG Metabolism

Status Completed

Clinical Trial Summary

Non-alcoholic fatty liver disease (NAFLD) covers a spectrum from reversible hepatic steatosis to inflammation and fibrosis termed steatohepatitis (NASH) and cirrhosis. New evidence indicates that NAFLD is associated with development of heart failure, abnormal ventricular glucose and fatty acid (FA) utilisation and cardiosteatosis. The mechanisms behind cardiac involvement and the progression from NAFL to NASH are poorly understood but must include altered cardiac and intrahepatic lipid handling. In collaboration with renowned research groups from Oxford, Mayo Clinic and Copenhagen we plan comprehensive kinetic studies of heart and liver FA uptake and oxidation, ventricular function and substrate utilisation, and hepatic triglyceride (TG) secretion in order to assess mechanisms governing cardiac and hepatic lipid and glucose trafficking in subjects with NAFL and NASH and the relationship with heart function. In addition, we will assess skeletal muscle and adipose tissue enzyme activities, gene expression and protein concentrations in these subjects to define mechanisms involved in the cross-talk between heart, liver, muscle and adipose tissues. We will address these questions using innovative tracer techniques (11Cpalmitate, 11C acetate, 18FDG glucose PET tracers and TG tracers) in combination with hepatic vein catherisation to study cardiac and liver substrate trafficking, as well as NMR spectroscopy, echocardiography, muscle and fat biopsies in combination with state-of-the art muscle and adipose tissue enzyme kinetics, gene- and protein expression. Effects of acute exercise as well as GLP-1 agonist and SGLT-2 inhibitor treatment (alone and in combination) will be assessed. The overarching goals are to define abnormalities and differences between NAFLD and NASH in hepatic lipid (FA and TG) metabolism and to assess hepatic, adipose and skeletal muscle lipid and substrate utilisation.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Fatty Liver
Liver Diseases
NAFLD - Nonalcoholic Fatty Liver Disease
NASH - Nonalcoholic Steatohepatitis
Non-alcoholic Fatty Liver Disease

Clinical Trial Details

NCT number	NCT03678727
Study type	Observational
Source	University of Aarhus
Contact
Status	Completed
Phase
Start date	December 1, 2018
Completion date	May 1, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03289897` - Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan	N/A
Recruiting	`NCT05479721` - LITMUS Imaging Study
Not yet recruiting	`NCT05120557` - Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH	N/A
Recruiting	`NCT04976283` - Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver	Phase 4
Completed	`NCT02784444` - A Study to Evaluate the Safety, Tolerability & Efficacy of MSDC-0602K in Patients With NASH	Phase 2
Not yet recruiting	`NCT05499949` - The Franciscus Obesity NASH Study
Completed	`NCT04321343` - Study of PXL065 in Patients With Nonalcoholic Steatohepatitis (NASH)	Phase 2
Recruiting	`NCT04371042` - PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies
Not yet recruiting	`NCT03648554` - Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST)	Phase 4
Completed	`NCT04972396` - ALT-801 DDI Study in Healthy Volunteers	Phase 1
Completed	`NCT03748628` - Absorption, Metabolism and Excretion (AME) Study of [14C]EDP-305 in Healthy Male Subjects	Phase 1
Enrolling by invitation	`NCT05195944` - Semaglutide vs Sitagliptin	Phase 4
Completed	`NCT04643795` - Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses of MGL-3196 in Subjects With Varying Degrees of Hepatic Impairment and Healthy Matched Control Subjects	Phase 1
Terminated	`NCT03669133` - Vitamin E for NASH Treatment in HIV Infected Individuals	Phase 2
Completed	`NCT04066400` - Role of a Wheat Containing Diet on Non-alcoholic Steatohepatitis	N/A
Completed	`NCT03536650` - Effect of DMR in the Treatment of NASH	N/A
Completed	`NCT03783897` - A Drug-drug Interaction Study to Investigate the Effect of Coadministration of EDP-305 on the PK of a Combined Oral Contraceptive in Healthy Female Subjects	Phase 1
Completed	`NCT04618744` - A Study to Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (NASH)	Phase 2
Active, not recruiting	`NCT05338034` - Phase 2a Study of HPG1860 in Subjects With NASH	Phase 2
Active, not recruiting	`NCT04653103` - NASH in Subjects With Different Classes of Obesity